Abstract
The Philadelphia (Ph1) chromosome in chronic myelogenous leukemia (CML) involves reciprocal translocation of the bcr gene and the c-abl oncogene. The fused bcr/abl gene is transcribed into two types of chimeric mRNA. By means of a combined method of S1 nuclease protection and polymerase chain reaction, we amplified sequences representative of the chimeric bcr/abl transcripts. Only 5 μg of total cellular RNA is needed and the chimeric bcr/abl message can be detected at a dilution of 1:100,000. We also detected residual chimeric bcr/abl transcripts in the remission samples from two Ph1-positive CML patients. This technique has the potential to identify a subpopulation of Ph1-positive CML patients in remission who are at high risk of relapse.
Original language | English (US) |
---|---|
Pages (from-to) | 893-897 |
Number of pages | 5 |
Journal | Blood |
Volume | 72 |
Issue number | 3 |
DOIs | |
State | Published - 1988 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology